EKSO (Ekso Bionics Holdings, Inc. Common Stock) Stock Analysis - SEC Filings

Ekso Bionics Holdings, Inc. Common Stock (EKSO) is a publicly traded Healthcare sector company. As of May 21, 2026, EKSO trades at $11.80 with a market cap of $42.05M and a P/E ratio of -2.40. EKSO moved -3.56% today. Year to date, EKSO is +151.06%; over the trailing twelve months it is +62.87%. Its 52-week range spans $2.73 to $18.15. Rallies surfaces EKSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find EKSO SEC filings?

Rallies organizes EKSO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

EKSO Key Metrics

Key financial metrics for EKSO
MetricValue
Price$11.80
Market Cap$42.05M
P/E Ratio-2.40
EPS$-4.91
Dividend Yield0.00%
52-Week High$18.15
52-Week Low$2.73
Volume0
Avg Volume0
Revenue (TTM)$12.80M
Net Income$-11.70M
Gross Margin53.48%

Latest EKSO News

Recent EKSO Insider Trades

  • Jones Jason C bought 1.31K (~$15.50K) on Mar 16, 2026.
  • Wong Jerome bought 1.31K (~$15.50K) on Mar 16, 2026.
  • ASHER DANIEL bought 15.54K (~$191.16K) on Feb 19, 2026.

EKSO Analyst Consensus

EKSO analyst coverage data. Average price target: $0.00.

Common questions about EKSO

Where can I find EKSO SEC filings?
Rallies organizes EKSO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show EKSO 10-K and 10-Q filings?
Rallies organizes EKSO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is EKSO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EKSO. It does not provide personalized investment advice.
EKSO

EKSO